Microbial metabolite receptors as mediators of pathogenic processes in Inflammatory Bowel Disease

被引：0
|
作者：
Spathakis, M. [1 ,2 ]
Dovrolis, N. [1 ,2 ]
Tarapatzi, G. [1 ,2 ]
Filidou, E. [1 ,2 ]
Kandilogiannakis, L. [1 ,2 ]
Valatas, V. [1 ,3 ]
Drygiannakis, I. [3 ]
Manolopoulos, V. G. [1 ,2 ]
Kolios, G. [1 ,2 ]
Arvanitidis, K. [1 ,2 ]
Vradelis, S. [4 ]
机构：
[1] Democritus Univ Thrace, Lab Pharmacol, Dept Med, Alexandroupolis, Greece
[2] Democritus Univ Thrace, Individualised Med & Pharmacol Res Solut Ctr IMPR, Alexandroupolis, Greece
[3] Univ Crete, Gastroenterol & Hepatol Res Lab, Dept Med, Iraklion, Greece
[4] Democritus Univ Thrace, Dept Internal Med, Dept Med, Alexandroupolis, Greece
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P021
引用
收藏
页码：I191 / I191
页数：1
相关论文
共 50 条
  • [41] Mucosal T cells: mediators or guardians of inflammatory bowel disease?
    Mudter, J
    Neurath, MF
    CURRENT OPINION IN GASTROENTEROLOGY, 2003, 19 (04) : 343 - 349
  • [42] Mediators of stress effects in inflammatory bowel disease: Not the usual suspects
    Maunder, R
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2000, 48 (06) : 569 - 577
  • [43] Inflammatory bowel disease: A potential pathogenic factor of Alzheimer?s disease
    Wang, Donghui
    Zhang, Xiaoshuang
    Du, Hongwu
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2022, 119
  • [44] Azathioprine formulation optimizes metabolite profile in inflammatory bowel disease
    Stevens, T
    Achkar, JP
    Easley, K
    Brzezinski, A
    Lashner, B
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (06) : 601 - 606
  • [45] Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease
    Weng, Yi Jie
    Gan, Huo Ye
    Li, Xiang
    Huang, Yun
    Li, Zheng Chao
    Deng, Hui Min
    Chen, Su Zuan
    Zhou, Yu
    Wang, Li Sheng
    Han, Yan Ping
    Tan, Ya Fang
    Song, Ya Jun
    Du, Zong Min
    Liu, Yang Yang
    Wang, Ye
    Qin, Nan
    Bai, Yang
    Yang, Rui Fu
    Bi, Yu Jing
    Zhi, Fa Chao
    JOURNAL OF DIGESTIVE DISEASES, 2019, 20 (09) : 447 - 459
  • [46] INFLAMMATORY MEDIATORS IN CHRONIC INFLAMMATORY BOWEL DISEASES
    GROSS, V
    ANDUS, T
    LESER, HG
    ROTH, M
    SCHOLMERICH, J
    KLINISCHE WOCHENSCHRIFT, 1991, 69 (21-23): : 981 - 987
  • [47] Mutations in innate immune receptors modulate the serologic response to microbial antigens in patients with inflammatory bowel disease
    Henckaerts, Liesbet
    Pierik, Marie
    Claes, Karolien
    Ferrante, Marc
    Vanschuerbeek, Nele
    Dotan, Nir
    Norman, Gary
    Altstock, Rom T.
    Dotan, Iris
    Schooler, Benjamin
    Shunts, Zakera
    Rutgeerts, Paul
    Vermeire, Severine
    GASTROENTEROLOGY, 2006, 130 (04) : A585 - A585
  • [48] Atherosclerosis and inflammatory bowel disease: Sharing a common pathogenic pathway?
    Danese, S
    Fiocchi, C
    CIRCULATION, 2003, 107 (07) : E52 - E52
  • [49] SCREENING FOR RARE PATHOGENIC SEQUENCE VARIANTS IN INFLAMMATORY BOWEL DISEASE
    Prescott, N. J.
    Lehne, B.
    Harrison, K.
    Knight, J.
    Weale, M.
    Simpson, M.
    Green, P.
    Lewis, C.
    Hart, A.
    Sanderson, J.
    Mansfield, J.
    Schlitt, T.
    Mathew, C.
    GUT, 2011, 60 : A62 - A62
  • [50] Involvement of Reduced Microbial Diversity in Inflammatory Bowel Disease
    Gong, Dawei
    Gong, Xiaojie
    Wang, Lili
    Yu, Xinjuan
    Dong, Quanjiang
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016, 2016
12345